Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
ESMO Open|January 21, 2021
Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancerA Adam-Artigues, I Garrido-Cano, S Simón, et al.
British Journal of Cancer|January 25, 2014
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trialE Alba, J Albanell, J de la Haba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancerJ Tabernero, M A Climent, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 3, 2014
Preventive treatments for breast cancer: recent developmentsJ E Alés-Martínez, A Ruiz, J I Chacón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)E M Ciruelos, J Cortés, H Cortés-Funes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 8, 2014
Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatmentM T Martínez, I González, N Tarazona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2011
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancerF Rojo, J García-Parra, S Zazo, et al.
Breast Cancer Research and Treatment|October 12, 2012
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter studyE Alba, J I Chacon, A Lluch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trialG Bianchini, L Pusztai, T Pienkowski, et al.
Pageof 18